MULTI INTENSIVE cream SPF15 50 ml

€133.00
Tax included
Quantity

  Security policy

(edit with the Customer Reassurance module)

  Delivery policy

(edit with the Customer Reassurance module)

  Return policy

(edit with the Customer Reassurance module)

Introducing CLARINS' MULTI-INTENSIVE Day Cream with SPF 15, designed for those who embrace life at 50 and beyond. This advanced formula tackles visible aging signs accelerated by hormonal shifts, offering specialized treatment with UV protection and an anti-pollution complex.

The cutting-edge formulation visibly enhances skin firmness and plumpness. Featuring organic Harungana extract—nature's alternative to retinol—collagen production is boosted significantly, alongside organic Argoma extract that aids in redensification and combats sagging. You’ll notice immediate brightness and smoothness, aided by line-filling pearls.

With regular use, experience skin that feels revitalized at every level, tightening, nourishing, and hydrating while minimizing the appearance of wrinkles. Key benefits include:

- Comprehensive skin redensification
- Firmness against sagging
- Instant radiance and smooth texture
- Long-lasting nourishment and hydration
- Stain prevention
- Protection against environmental damage

*Results from in vivo and ex vivo studies. Notably, 88% of participants reported denser and plumper skin, while 85% felt their skin appeared firmer after 28 days of use, based on feedback from a diverse group of 111 women.

Clarins has expertly combined two powerful botanical extracts known for their revitalizing and tightening properties: Harungana bio and Argoma bio. The synergy of these ingredients is key to achieving optimal anti-sagging results.
CLARINS
825-65754
120 Items

Data sheet

Gender
Woman
CompleteFamilies
Cosmética Facial/Tratamientos Faciales
Contenido
50 ml
Tendencias
Skinimalism
Texturas
Crema
Piel
Todo Tipo de Pieles
Edad
Más de 50 años
Protección SPF
Media SPF 15
Tratamiento
Día

Specific References

EAN13
3666057265754
Comments (0)
No customer reviews for the moment.